Therapeutics

400+ Companies
Companies
464
Established hub
Deals 2021 Q2
6 investments
2 acquisitions
Index Pro Account
Upgrade your account to download a CSV export of companies on any list
Pulse 2.0

CYTO Stock Price Increases Over 25% Intraday: Why It Happened

Pulse 2.0

KPTI Stock Price Increases Over 7% Pre-Market: Why It Happened

Pulse 2.0

MNPR Stock Price Increases Over 6% Pre-Market: Why It Happened

Pulse 2.0

ARCT Stock Price Increases Over 6% Pre-Market: Why It Happened

Pulse 2.0

OTLK Stock Price Increases Over 30% Pre-Market: Why It Happened

Pulse 2.0 , MedCity News

Why Sanofi (SNY) Is Buying Translate Bio (TBIO) For $3.2 Billion

TechCrunch

Rani Therapeutics’ $73M IPO will fund upcoming clinical trials

Pulse 2.0

HOTH Stock Increases Over 6% Intraday: Why It Happened

Pulse 2.0

AUTL Stock Increases Over 15% Pre-Market: Why It Happened

MedCity News

5 days, 11 life science IPOs & more than $1.3B in new capital

Pulse 2.0

NAOV Stock Increased 26.18%: Why It Happened

TechCrunch

Biofourmis receives FDA breakthrough device designation for heart failure “digital therapy”

Pulse 2.0

ACER Stock Increases Over 20% Pre-Market: Why It Happened

$117,000,000 Venture capital (Series B)
MedCity News

Ring Therapeutics rounds up $117M to find better viral vectors for gene therapy

CAD $226,000,000 Venture capital (Series C)
BetaKit , MedCity News

Deep Genomics secures $226 million CAD led by SoftBank as it scales AI drug discovery platform

TechCrunch

BioNTech founder Uğur Şahin and Mayfield’s Ursheet Parikh are coming to Disrupt

Forbes Tech

Scalable Automation Is Breaking The Bottleneck On Cell Therapy Manufacturing

MedCity News

Amgen adds antibody assets and R&D tech with $900M Teneobio acquisition

MedCity News

CEO of digital therapeutics business Freespira talks about its approach to anxiety disorders

MedCity News

AC Immune picks up Phase 2-ready drug for Parkinson’s in $58M deal with Affiris